Loading clinical trials...
Loading clinical trials...
Role of Strontium Ranelate in Radiological Healing of Proximal Femur Fractures. A Phase IV Double Blinded Randomized Controlled Trial
This study is being conducted with the aim of comparing the time to bone healing after surgery for fragility fractures of proximal femur between patients receiving strontium ranelate and placebo. Patients recruited are of 60 years of age and above. Bone healing will be assessed on clinical parameters when patient is able to ambulate full weight bearing without pain and on Xray images using RUSH score. Moreover Dexa scan will be performed pre-operatively and at 3 months postoperatively. The findings of this study will help in setting up guidelines for treatment of fragility proximal femur fractures in our population as there is still paucity of literature on effectiveness of strontium ranelate from our part of the world.
Age
60 - 100 years
Sex
ALL
Healthy Volunteers
No
Aga Khan University Hospital
Karachi, Sindh, Pakistan
Start Date
November 1, 2021
Primary Completion Date
November 30, 2023
Completion Date
June 30, 2024
Last Updated
February 3, 2023
100
ESTIMATED participants
Strontium Ranelate
DRUG
Lacto-N-Hexaose
DRUG
Lead Sponsor
Aga Khan University Hospital, Pakistan
Collaborators
NCT07256522
NCT05851898
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions